Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan
· Delayed Price · Currency is TWD 398.00
+8.00 (2.05%)
Dec 5, 2025, 1:29 PM CST
Sunmax Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 21,676 | 15,250 | 11,110 | 7,407 | 4,499 | 4,384 | Upgrade
|
| Market Cap Growth | 41.64% | 37.26% | 50.00% | 64.65% | 2.61% | 0.37% | Upgrade
|
| Enterprise Value | 21,064 | 14,751 | 10,469 | 6,785 | 3,756 | 3,685 | Upgrade
|
| Last Close Price | 398.00 | 272.27 | 191.22 | 122.37 | 71.74 | 68.23 | Upgrade
|
| PE Ratio | 30.27 | 22.45 | 17.76 | 13.88 | 18.31 | 18.42 | Upgrade
|
| PS Ratio | 10.85 | 8.39 | 6.58 | 5.29 | 4.34 | 5.12 | Upgrade
|
| PB Ratio | 15.01 | 10.08 | 7.79 | 5.59 | 4.39 | 4.93 | Upgrade
|
| P/TBV Ratio | 15.09 | 10.12 | 7.82 | 5.61 | 4.41 | 4.96 | Upgrade
|
| P/FCF Ratio | 27.79 | 28.82 | 15.00 | 15.12 | - | 17.05 | Upgrade
|
| P/OCF Ratio | 26.90 | 27.18 | 13.09 | 11.49 | 18.49 | 11.33 | Upgrade
|
| EV/Sales Ratio | 10.55 | 8.11 | 6.20 | 4.85 | 3.63 | 4.31 | Upgrade
|
| EV/EBITDA Ratio | 19.38 | 14.83 | 11.18 | 8.47 | 9.45 | 10.66 | Upgrade
|
| EV/EBIT Ratio | 21.37 | 15.91 | 11.70 | 8.84 | 10.22 | 11.09 | Upgrade
|
| EV/FCF Ratio | 27.01 | 27.88 | 14.13 | 13.85 | - | 14.33 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.10 | 0.12 | 0.05 | 0.10 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.11 | 0.14 | 0.17 | 0.08 | 0.23 | 0.35 | Upgrade
|
| Debt / FCF Ratio | 0.16 | 0.27 | 0.23 | 0.13 | - | 0.51 | Upgrade
|
| Asset Turnover | 1.06 | 0.86 | 0.86 | 0.85 | 0.73 | 0.69 | Upgrade
|
| Inventory Turnover | 2.78 | 2.70 | 3.39 | 3.23 | 3.53 | 4.65 | Upgrade
|
| Quick Ratio | 3.08 | 2.72 | 2.12 | 2.52 | 2.06 | 3.12 | Upgrade
|
| Current Ratio | 3.86 | 3.32 | 2.36 | 2.78 | 2.36 | 3.28 | Upgrade
|
| Return on Equity (ROE) | 51.00% | 46.24% | 45.48% | 45.45% | 25.69% | 30.41% | Upgrade
|
| Return on Assets (ROA) | 32.72% | 27.24% | 28.30% | 29.29% | 16.12% | 16.77% | Upgrade
|
| Return on Capital (ROIC) | 39.88% | 35.62% | 37.49% | 38.23% | 21.44% | 22.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 59.50% | 52.50% | 52.60% | 52.30% | 31.90% | 31.10% | Upgrade
|
| Earnings Yield | 3.31% | 4.46% | 5.63% | 7.21% | 5.46% | 5.43% | Upgrade
|
| FCF Yield | 3.60% | 3.47% | 6.67% | 6.62% | -0.22% | 5.86% | Upgrade
|
| Dividend Yield | 2.97% | 4.26% | 5.75% | 7.76% | 6.13% | 2.93% | Upgrade
|
| Payout Ratio | 88.12% | 88.18% | 82.69% | 44.89% | 44.34% | 34.31% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.00% | 0.01% | -0.03% | 0.02% | 0.00% | Upgrade
|
| Total Shareholder Return | 2.97% | 4.26% | 5.76% | 7.74% | 6.16% | 2.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.